سٹیم سیل ٹرانسپلانٹ کے بعد کیئر
Study to Evaluate the Safety and Effectiveness of Withaferin A as a Treatment to Prevent GvHD in Transplant Patients
کہاں جانا ہے
اس ٹرائل کے لیے انڈیا کے 2 ہسپتالوں میں مریضوں کو لیا جا رہا ہے۔
رجسٹری کی سمری (ٹیکنیکل)
What is acute Graft versus host disease (aGvHD)? GvHD is a complication that can occur after an allogeneic stem cell transplant resulting in damage to some organs. The death rate of GvHD patients is 15-40%. In GvHD, the donated peripheral blood stem cells or bone marrow view the recipient's body as foreign, and the donated cells/bone marrow harm the body. aGvHD usually develops in skin, liver or gastrointestinal tract, and symptoms might appear within few weeks after transplant. Symptoms of acute GvHD are observed as skin rash or reddened areas on the skin, yellow discoloration of the skin and…
Sponsor: Tata Memorial Centre
ClinicalTrials.gov پر NCT07724873
رجسٹری پر آخری اپڈیٹ 24 Jul 2026 · ہم نے 20 Oct 2026 کو پڑھا